Pacira BioSciences PCRX
NASDAQ PCRX
$36.42 +0.08 (+0.22%)
At close: Oct 23, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Sale and Maturity of Investments (2011 - 2026)

Updated

Analysis

Pacira BioSciences (PCRX) Sale and Maturity of Investments (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Pacira BioSciences 1.45 Bn 512.36 Mn 148.24 Mn 17.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.00 Mn
Mar 31, 2026 22.50 Mn
Dec 31, 2025 47.14 Mn
Sep 30, 2025 86.25 Mn
Jun 30, 2025 71.17 Mn
Mar 31, 2025 69.25 Mn
Dec 31, 2024 46.95 Mn
Sep 30, 2024 53.17 Mn
Jun 30, 2024 36.10 Mn
Mar 31, 2024 43.36 Mn
Dec 31, 2023 36.10 Mn
Sep 30, 2023 41.23 Mn
Jun 30, 2023 33.50 Mn
Mar 31, 2023 126.25 Mn
Dec 31, 2022 84.94 Mn
Sep 30, 2022 89.70 Mn
Jun 30, 2022 62.94 Mn
Dec 31, 2021 598.12 Mn
Sep 30, 2021 176.33 Mn
Jun 30, 2021 158.06 Mn
API Access

Pacira BioSciences Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=PCRX&period=max&api_key=YOUR_API_KEY